212 W 10TH ST STE A480
INDIANAPOLIS, IN, 46202-5608


DUNS: 963580894
# of Employees: 2

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts

Award Listing

  1. Chemical enhancement of CRISPR/Cas9 mediated site-specific genome engineering

    Amount: $293,005.00

    DESCRIPTION provided by applicant Chemical enhancement of CRISPR Cas mediated site specific genome engineering Abstract Programmable nucleases including Zinc Finger Nucleases TALENs meganuclea ...

    SBIRPhase I2016Department of Health and Human Services
  2. A new generation of targeted therapeutics for the treatment of cancer.

    Amount: $299,275.00

    DESCRIPTION provided by applicant Development of novel lung cancer therapeutics targeting the DNA damage response Abstract Lung tissue is constantly exposed to a wide variety of inhaled chemical a ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Development of Novel Agents Targeting Genome Stability and Maintenance for Treati

    Amount: $229,680.00

    DESCRIPTION (provided by applicant): Epithelial ovarian cancer (EOC) is uniformly fatal once resistance to platinum based therapy (Pt) is observed. Innate resistance is observed in approximately 25% o ...

    STTRPhase I2012Department of Health and Human Services
  4. Targeting the ERCC1/XPF nuclease for cancer therapy

    Amount: $299,922.00

    DESCRIPTION (provided by applicant): Platinum based agents (Pt) are the most commonly prescribed chemotherapeutics used in the treatment of solid tumors and are part of the curative treatment regimen ...

    SBIRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government